Project Grant HT94252310599
Award Date 7/1/23
Completion Date 6/30/27
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
- The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
- The Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division in Omaha, Nebraska, received a $2.0 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2025 through May 31, 2028. The award supports advanced biomedical research investigating the interrelationship between PINK1-PRKN pathway disruption and tauopathy in the...
- The Defense Health Agency awarded a $602,814 Project Grant to the University of Nebraska Medical Center (UNMC) under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period from November 1, 2024 to October 31, 2027, supports research to investigate "Targeting Extracellular Nucleoside Metabolism as a Strategy to Potentiate the Effects of Immunotherapy in Pancreatic Ductal Adenocarcinoma." The project aims to explore innovative approaches...
- Federal Project Grant Award Summary The University of Nebraska Medical Center (UNMC) received a $848,335 project grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, for a three-year performance period ending July 31, 2028. The grant supports research on a novel therapeutic approach to prevent uveal melanoma progression. As a leading academic research institution with substantial experience in oncology...
- Federal Grant Award Summary The University of Nebraska Medical Center received a $309,000 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded on November 15, 2025, with a completion date of November 14, 2027. The award funds research investigating the role of the axonal guidance molecule neuropilin-2 (NRP2) in promoting perineural invasion (PNI) and pain in pancreatic ductal adenocarcinoma (PDAC) patients. This basic...
- Federal Project Grant Award Summary The Feinstein Institutes For Medical Research received a $299,991 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective October 1, 2025, through September 30, 2027. The award funds research investigating the proinflammatory function and heterogeneity of age-associated B cells in systemic lupus erythematosus (SLE). This hypothesis-driven research initiative will be conducted at...
- This Defense Health Agency Project Grant award of $1,204,899 to Duke University, with a period of performance from January 1, 2024 to December 31, 2027, supports targeted vaccination research to treat and prevent endocrine-resistant ER+ breast cancer. The project aims to develop new treatments by targeting common resistance genes and neoepitope mutations. This grant is funded through the Department of Defense's Military Medical Research and Development program (CFDA 12.420), which supports...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.344 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2029. The award supports research on targeting noncanonical Wnt signaling to prevent Ewing sarcoma metastases utilizing a novel zebrafish model. This research addresses a critical cancer biology challenge relevant to military medical...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.25 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026, through March 31, 2029. The award supports research into immunosuppressive mechanisms in breast cancer stem cells to develop new immunotherapy approaches. This three-year research initiative will be conducted at the institution's facilities in the...
- This federal Project Grant award for $772,501.00, awarded on May 1, 2024 by the Defense Health Agency, supports the University of Nebraska Medical Center's research project titled "BUTYRYLCHOLINESTERASE: AN OUTSTANDING DIAGNOSTIC AND DRUGGABLE BIOMARKER IN UVEAL MELANOMA." The project, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance research into butyrylcholinesterase as a diagnostic and therapeutic target for uveal melanoma, a rare and...